Read the latest news from the MassBio community! This space is for members to share company updates and press releases. Members may not post stories that are copyrighted by news publications or post sales pitches.
uniQure N.V. (Nasdaq: QURE), a leader in human gene therapy, today announced new and updated results from its ongoing, dose-ranging Phase I/II trial of AMT-060, its proprietary, investigational gene therapy in patients... Read More
The new NGS module Read More
Charles River Laboratories International, Inc. today launched a full, end-to-end service offering of CRISPR/Cas9 genome engineering technology. Read More
PCI Synthesis, Inc. (www.pcisynthesis.com), a drug substance Contract Manufacturing Organization (CMO) of new chemical entities (NCEs) and generic active pharmaceutical ingredients (APIs), announced that it won the 2016... Read More
Addgene has been named the #1 small company to work at in Massachusetts in the ninth annual employee-based survey project from The Boston Globe. Read More
A late clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, today provides an update on the global development of its lead product, NBTXR3, across all indications. NBTXR3 is... Read More
Shire plc (LSE: SHP, NASDAQ: SHPG) announced today that it will expand its operations in Cambridge, Massachusetts, establishing a rare disease innovation hub and increasing its footprint in the heart of Kendall Square.... Read More
For peptide drug substances in early clinical development there is often a very strong focus on fast drug substance supply. Therefore, development of manufacturing process capabilities and process economy, purity and impurity... Read More
The Charles River team of leading Central Nervous System (CNS) and neurological disease experts presented 25 scientific posters and one podium presentation, both independently and collaboratively with clients, at Neuroscience... Read More
After writing several guest articles for the Timmerman Report, Altius Strategy Consulting’s Principal, Leora Schiff, has joined the TR team as a regular contributor. Read More